Review
doi: 10.1097/00004424-198501002-00004.Toxicology of iohexol
- PMID:3882609
- DOI: 10.1097/00004424-198501002-00004
Item in Clipboard
Review
Toxicology of iohexol
D D Shaw et al. Invest Radiol.1985 Jan-Feb.
Display options
Format
Display options
Format
Abstract
This review summarizes the biological profile of the nonionic contrast medium, iohexol, with particular emphasis on neurovascular and myelographic applications. Iohexol was compared with conventional ionic media and with newer nonionic agents in a variety of animal models. Studies of systemic toxicity (teratogenicity, mutagenicity, and embryotoxicity effects) and cerebrovascular effects (epileptogenicity and arachnoiditis potential) are reported. Results indicate that iohexol has a lower toxicity than ionic and other nonionic contrast media.
Similar articles
- Intrathecal toxicity of iohexol vs. metrizamide. Survey and current state.Haughton VM.Haughton VM.Invest Radiol. 1985 Jan-Feb;20(1 Suppl):S14-7. doi: 10.1097/00004424-198501002-00005.Invest Radiol. 1985.PMID:3918951
- Acute intravenous toxicity of iohexol in the mouse and in the rat.Salvesen S.Salvesen S.Acta Radiol Suppl. 1980;362:73-5.Acta Radiol Suppl. 1980.PMID:6267895
- The toxicity of the non-ionic water-soluble contrast media iohexol and metrizamide (Amipaque) in selective vertebral angiography. An experimental study in rabbits.Skalpe IO.Skalpe IO.Neuroradiology. 1981 Jan;20(5):235-9. doi: 10.1007/BF00342090.Neuroradiology. 1981.PMID:7465042
- Experimental investigations with iohexol and their clinical relevance.Almén T.Almén T.Acta Radiol Suppl. 1983;366:9-19.Acta Radiol Suppl. 1983.PMID:6206690Review.
- Neurotoxicity of water-soluble contrast media.Torvik A, Walday P.Torvik A, et al.Acta Radiol Suppl. 1995;399:221-9. doi: 10.1177/0284185195036s39927.Acta Radiol Suppl. 1995.PMID:8610520Review.
Cited by
- The use of iodinated and gadolinium contrast media during pregnancy and lactation.Webb JA, Thomsen HS, Morcos SK; Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR).Webb JA, et al.Eur Radiol. 2005 Jun;15(6):1234-40. doi: 10.1007/s00330-004-2583-y. Epub 2004 Dec 18.Eur Radiol. 2005.PMID:15609057
- An overview of the clinical pharmacokinetics of x-ray contrast media.Bourin M, Jolliet P, Ballereau F.Bourin M, et al.Clin Pharmacokinet. 1997 Mar;32(3):180-93. doi: 10.2165/00003088-199732030-00002.Clin Pharmacokinet. 1997.PMID:9084958Review.
- Updated guidelines for intravenous contrast use for CT and MRI.Huynh K, Baghdanian AH, Baghdanian AA, Sun DS, Kolli KP, Zagoria RJ.Huynh K, et al.Emerg Radiol. 2020 Apr;27(2):115-126. doi: 10.1007/s10140-020-01751-y. Epub 2020 Jan 10.Emerg Radiol. 2020.PMID:31925592Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources